- Home
- LIEN vs HRTX Comparison
LIEN vs HRTX Comparison
Compare LIEN & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIEN
- HRTX
- Stock Information
- Founded
- LIEN 2021
- HRTX 1983
- Country
- LIEN United States
- HRTX United States
- Employees
- LIEN N/A
- HRTX N/A
- Industry
- LIEN
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- LIEN
- HRTX Health Care
- Exchange
- LIEN NYSE
- HRTX Nasdaq
- Market Cap
- LIEN 278.9M
- HRTX 270.7M
- IPO Year
- LIEN 2022
- HRTX 1987
- Fundamental
- Price
- LIEN $12.01
- HRTX $2.32
- Analyst Decision
- LIEN
- HRTX Strong Buy
- Analyst Count
- LIEN 0
- HRTX 3
- Target Price
- LIEN N/A
- HRTX $5.67
- AVG Volume (30 Days)
- LIEN 5.7K
- HRTX 2.6M
- Earning Date
- LIEN 05-08-2025
- HRTX 05-06-2025
- Dividend Yield
- LIEN 12.06%
- HRTX N/A
- EPS Growth
- LIEN N/A
- HRTX N/A
- EPS
- LIEN 0.67
- HRTX N/A
- Revenue
- LIEN $12,681,914.00
- HRTX $144,285,000.00
- Revenue This Year
- LIEN $71.81
- HRTX $11.81
- Revenue Next Year
- LIEN $113.93
- HRTX $15.79
- P/E Ratio
- LIEN $17.39
- HRTX N/A
- Revenue Growth
- LIEN 22.94
- HRTX 13.57
- 52 Week Low
- LIEN $8.38
- HRTX $1.04
- 52 Week High
- LIEN $13.38
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- LIEN N/A
- HRTX 59.27
- Support Level
- LIEN N/A
- HRTX $2.25
- Resistance Level
- LIEN N/A
- HRTX $2.45
- Average True Range (ATR)
- LIEN 0.00
- HRTX 0.24
- MACD
- LIEN 0.00
- HRTX 0.01
- Stochastic Oscillator
- LIEN 0.00
- HRTX 65.05
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.